Although the epidemic caused by SARS‐CoV‐2 callings for international attention to develop new effective therapeutics, no specific protocol is yet available, leaving patients to rely on general and supportive therapies. A range of respiratory diseases, including pulmonary fibrosis, have been associated with higher iron levels that may promote the course of viral infection. Recent studies have demonstrated that some natural components could act as the first barrier against viral injury by affecting iron metabolism. Moreover, a few recent studies have proposed the combination of protease inhibitors for therapeutic use against SARS‐CoV‐2 infection, highlighting the role of viral protease in virus infectivity. In this regard, this review focuses on the analysis, through literature and docking studies, of a number of natural products able to counteract SARS‐CoV‐2 infection, acting both as iron chelators and protease inhibitors.

Role of iron chelation and protease inhibition of natural products on covid‐19 infection

Carota G.
Primo
Conceptualization
;
Ronsisvalle S.
Secondo
Conceptualization
;
Tibullo D.
Membro del Collaboration Group
;
Nicolosi A.
Penultimo
Membro del Collaboration Group
;
Li Volti G.
Ultimo
Supervision
2021

Abstract

Although the epidemic caused by SARS‐CoV‐2 callings for international attention to develop new effective therapeutics, no specific protocol is yet available, leaving patients to rely on general and supportive therapies. A range of respiratory diseases, including pulmonary fibrosis, have been associated with higher iron levels that may promote the course of viral infection. Recent studies have demonstrated that some natural components could act as the first barrier against viral injury by affecting iron metabolism. Moreover, a few recent studies have proposed the combination of protease inhibitors for therapeutic use against SARS‐CoV‐2 infection, highlighting the role of viral protease in virus infectivity. In this regard, this review focuses on the analysis, through literature and docking studies, of a number of natural products able to counteract SARS‐CoV‐2 infection, acting both as iron chelators and protease inhibitors.
COVID‐19
Iron chelation
Natural products
Protease inhibition
SARS‐Cov‐2
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/20.500.11769/526468
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 9
social impact